Li Ming-Chu, Deng Yong-Wen, Wu Jun, Chen Feng-Hua, Liu Jin-Fang, Fang Jia-Sheng
Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P. R. China.
Ai Zheng. 2006 Feb;25(2):241-6.
BACKGROUND & OBJECTIVE: Tumor stem cells have been isolated from several kinds of solid tumors, including primary brain tumors such as glioma and medulloblastoma. This investigation was to establish a simplified culture system to isolate and passage brain tumor stem cells (BTSCs) from human medulloblastoma, observe their proliferation and differentiation, and determine the expression of normal neural stem cell antigens, CD133 and Nestin, in BTSCs.
Eleven specimens of medulloblastoma were acutely dissociated and triturated into single cells without trypsin digestion. The tumor cells were seeded into serum-free DMEM/F12 medium (200,000 viable cells/ml) containing B27 (1:50), basic fibroblast growth factor (bFGF, 20 microg/L), epidermal growth factor (EGF, 20 microg /L), insulin (4 u/L), L-glutamine, and antibiotics. After generation, the primary brain tumor spheres (BTSs) were mechanically dissociated and passaged in the above serum-free medium. The monoclonal formation experiment was performed to determine the proportion of BTSCs in medulloblastoma and to observe the formation of BTSs. The differentiation of BTSCs was induced in mitogen-free DMEM/F12 medium supplemented with 10% fetal bovine serum. The expression of CD133 and Nestin in BTSs was observed with immunofluorescence staining; the distribution of CD133-positive cells in tumor sections was assessed by immunohistochemistry.
In each of the 11 specimens, only a minority of medulloblastoma cells showed the capacity of self-renew and proliferation. These BTSCs generated free-floating neurosphere-like BTSs in the simplified serum-free medium. The proportion of BTSCs with monoclonal formation capacity in primary tumor cells was (31.18+/-6.18)%. The BTSCs attached to poly-L-lysine-coated coverslips and differentiated when the serum-supplemented medium was added. The expression of CD133 and Nestin was detected in BTSCs. CD133-positive cells scattered or formed nest-like aggregations in tumor masses, and accounted for (33.06+/-8.57)% of all tumor cells.
BTSCs, with the capacity of self-renew and proliferation and express CD133 and Nestin, are exist in human medulloblastoma. They could be isolated and cultured in the simplified serum-free medium, and their differentiation could be induced in serum-supplemented medium.
肿瘤干细胞已从多种实体瘤中分离出来,包括原发性脑肿瘤,如胶质瘤和髓母细胞瘤。本研究旨在建立一种简化的培养系统,从人髓母细胞瘤中分离并传代脑肿瘤干细胞(BTSCs),观察其增殖和分化情况,并检测BTSCs中正常神经干细胞抗原CD133和巢蛋白的表达。
11例髓母细胞瘤标本不经胰蛋白酶消化,直接进行急性解离并研磨成单细胞。将肿瘤细胞接种于含B27(1:50)、碱性成纤维细胞生长因子(bFGF,20μg/L)、表皮生长因子(EGF,20μg/L)、胰岛素(4U/L)、L-谷氨酰胺和抗生素的无血清DMEM/F12培养基(200,000个活细胞/ml)中。传代后,将原代脑肿瘤球(BTSs)进行机械解离,并在上述无血清培养基中传代。进行单克隆形成实验以确定髓母细胞瘤中BTSCs的比例,并观察BTSs的形成。在添加10%胎牛血清的无丝分裂原DMEM/F12培养基中诱导BTSCs分化。用免疫荧光染色观察BTSs中CD133和巢蛋白的表达;通过免疫组织化学评估肿瘤切片中CD133阳性细胞的分布。
在11例标本中,每例仅有少数髓母细胞瘤细胞具有自我更新和增殖能力。这些BTSCs在简化的无血清培养基中形成了游离的神经球样BTSs。原代肿瘤细胞中具有单克隆形成能力的BTSCs比例为(31.18±6.18)%。当添加含血清培养基时,BTSCs附着于聚-L-赖氨酸包被的盖玻片上并发生分化。在BTSCs中检测到CD133和巢蛋白的表达。CD133阳性细胞在肿瘤块中散在分布或形成巢状聚集,占所有肿瘤细胞的(33.06±8.57)%。
人髓母细胞瘤中存在具有自我更新和增殖能力且表达CD133和巢蛋白的BTSCs。它们可在简化的无血清培养基中分离培养,并在含血清培养基中诱导其分化。